Howmet Aerospace to Present at Goldman Sachs Industrials & Materials Conference

PITTSBURGH--(BUSINESS WIRE)-- Howmet Aerospace Inc. (NYSE: HWM) announced today that John C. Plant, Chairman and Co-Chief Executive Officer, Tolga Oal, Co-Chief Executive Officer, and Ken Giacobbe, Executive Vice President and Chief Financial Officer, will speak at the Virtual Goldman Sachs Industrials & Materials Conference on Thursday, May 13, 2021 at 9:40 AM ET.

A real-time webcast of the event will be available on the “Investors/Events and Presentations” section of www.howmet.com, where a webcast replay will be available for 30 days following the presentation.

About Howmet Aerospace

Howmet Aerospace Inc., headquartered in Pittsburgh, Pennsylvania, is a leading global provider of advanced engineered solutions for the aerospace and transportation industries. The Company’s primary businesses focus on jet engine components, aerospace fastening systems, and titanium structural parts necessary for mission-critical performance and efficiency in aerospace and defense applications, as well as forged wheels for commercial transportation. With nearly 1,150 granted and pending patents, the Company’s differentiated technologies enable lighter, more fuel-efficient aircraft to operate with a lower carbon footprint. For more information, visit www.howmet.com. Follow: LinkedIn, Twitter, Instagram, Facebook, and YouTube.

Dissemination of Company Information

Howmet Aerospace intends to make future announcements regarding Company developments and financial performance through its website at www.howmet.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005076/en/

Investor Contact
Paul T. Luther
(412) 553-1950
[email protected]

Media Contact
Paul Erwin
(412) 553-2666
[email protected]

Source: Howmet Aerospace Inc.

You May Also Be Interested In

• The Board of Directors of TotalEnergies Reaffirms the Relevance of the Company’s Strategy and Its Confidence in the Governance & Management to Continue Its Implementation
• Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer
• CHERY CSH Black Sea Safety Challenge Concludes Successfully